The Department of Health Care Services (DHCS) posted the following alerts, weekly notices, and monthly bulletin on the Medi-Cal Rx Web Portal. Please note the “Maximum Allowable Ingredient Cost 30-Day Pharmacy Provider Notice”; rates will be effective January 1, 2024, and will be posted to the Mercer Med-Cal Rx website no later than December 1, 2023. Also note the “Commercial COVID-19 Vaccine Coverage for Children” alert providing an updated policy whereby COVID-19 vaccines are a Medi-Cal Rx pharmacy benefit for members three years of age and older.
- Medi-Cal Rx Weekly Wrap-up for November 17-30 (December 1)
- Reinstatement Spotlight (December 1)
- 30-day Countdown: Medi-Cal Managed Care Plan Transition (December 1)
- Maximum Allowable Ingredient Cost 30-day Pharmacy Provider Notice (December 1)
- Medical Supplies Updates: Updates to Contracted Pen Needles, Insulin Syringes, and Sterile Syringes with Needles (Non-Insulin), Effective January 1, 2024 (December 1)
- Medical Supplies Update: Updates to Diabetic Testing Supplies, Effective January 1, 2024 (December 1)
- Medical Supplies Update: Updates to List of Contracted Self-Monitoring Blood Glucose Systems (Glucometers), Control Solutions, and Lancing Devices, Effective January 1, 2024 (December 1)
- Updates to the List of Contracted Enteral Nutrition Products, Effective January 1, 2024 (December 1)
- Medi-Cal Rx Monthly Bulletin for December (December 1)
- Changes to the Medi-Cal Rx Contract Drugs List (December 1)
- Updates to the Medi-Cal Rx Provider Manual (December 1)
- Commercial COVID-19 Vaccine Coverage for Children (November 29)
- Paper Remittance Advice: Dollar Sign Placement Update (November 22)
- Reinstatement Spotlight (November 17)
Also in California, the Board of Pharmacy provided this important alert and reminder to licensees about the drug xylazine.
For more information, contact NACDS’ Sandra Guckian at 703-774-4801.